TXMD (TherapeuticsMD) Net Interest Margin (Bank Only) %


TXMD TherapeuticsMD Inc TXMD
54 GF Score
Price $2.24
GF Value $2.07
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is TherapeuticsMD Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

TXMD
54GF Score
TherapeuticsMD Inc TXMD
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TherapeuticsMD (TXMD) Overvalued in 2026?

Based on GuruFocus' analysis, TherapeuticsMD stock appears to be overvalued. The current stock price of $2.24 is trading 8.2% above its estimated GF Value™ of $2.07. GuruFocus considers TherapeuticsMD to be Fairly Valued.

Key valuation signals for TXMD:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $2.07 vs. price of $2.24 (8.2% above fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the TXMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TherapeuticsMD Business Description

Other Exchanges 29TA:Germany
Address 951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
54GF Score

Get the complete analysis for TXMD

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price
$2.07
GF Value